Home » ANGIOTECH SHARES UP ON TAXUS REGISTRY DATA
ANGIOTECH SHARES UP ON TAXUS REGISTRY DATA
Shares of Canada's Angiotech Pharmaceuticals Inc. rose Tuesday after its partner Boston Scientific Corp. said preliminary six-month registry data for its Taxus Express2 drug-coated heart stent confirmed previous safety data. The Houston Chronicle (http://www.chron.com/disp/story.mpl/ap/fn/3723623.html)
KEYWORDS FDAnews Device Daily Bulletin
Upcoming Events
-
07May
-
14May
-
30May